SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 167 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $115,000 | 0.0% | 11,100 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $115,000 | -2.5% | 11,100 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $118,000 | -4.1% | 11,100 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $123,000 | -24.1% | 11,100 | -7.5% | 0.00% | -50.0% |
Q4 2016 | $162,000 | -19.8% | 12,000 | -38.5% | 0.00% | 0.0% |
Q1 2016 | $202,000 | -50.4% | 19,500 | -15.2% | 0.00% | -60.0% |
Q4 2015 | $407,000 | -9.8% | 23,000 | +1.3% | 0.01% | -16.7% |
Q3 2015 | $451,000 | +26.0% | 22,700 | +4.1% | 0.01% | +50.0% |
Q2 2015 | $358,000 | +9.5% | 21,800 | +3.8% | 0.00% | 0.0% |
Q1 2015 | $327,000 | -0.6% | 21,000 | -11.4% | 0.00% | 0.0% |
Q4 2014 | $329,000 | +94.7% | 23,700 | -8.8% | 0.00% | +100.0% |
Q3 2014 | $169,000 | -4.0% | 26,000 | +2.0% | 0.00% | -33.3% |
Q2 2014 | $176,000 | -6.9% | 25,500 | -3.8% | 0.00% | 0.0% |
Q1 2014 | $189,000 | -16.7% | 26,500 | +10.4% | 0.00% | -25.0% |
Q4 2013 | $227,000 | +54.4% | 24,000 | +2.1% | 0.00% | +33.3% |
Q3 2013 | $147,000 | +0.7% | 23,500 | +9.3% | 0.00% | 0.0% |
Q2 2013 | $146,000 | – | 21,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |